Department
Natural Sciences
Document Type
Article
Publication Source
Journal of Orthopaedic Surgery and Research
Publication Date
2017-05-04
Volume
12
Issue
1
First Page
69
Last Page
69
Abstract
Background: Heterotopic ossification (HO) is a significant problem for wounded warriors surviving high-energy blast injuries; however, currently, there is no biomarker panel capable of globally characterizing, diagnosing, and monitoring HO progression. The aim of this study was to identify biomarkers for HO using proteomic techniques and blood serum.
Methods: Isobaric tags for relative and absolute quantitation (iTRAQ) was used to generate a semi-quantitative global proteomics survey of serum from patients with and without heterotopic ossification. Leveraging the iTRAQ data, a targeted selection reaction monitoring mass spectrometry (SRM-MS) assay was developed for 10 protein candidates: alkaline phosphatase, osteocalcin, alpha-2 type I collagen, collagen alpha-1(V) chain isoform 2 preprotein, bone sialoprotein 2, phosphatidate phosphatase LPIN2, osteomodulin, protein phosphatase 1J, and RRP12-like protein.
Results: The proteomic survey of serum from both healthy and disease patients includes 1220 proteins and was enriched for proteins involved in the response to elevated platelet Ca+2, wound healing, and extracellular matrix organization. Proteolytic peptides from three of the ten SRM-MS proteins, osteocalcin preprotein, osteomodulin precursor, and collagen alpha-1(v) chain isoform 2 preprotein from serum, are potential clinical biomarkers for HO.
Conclusions: This study is the first reported SRM-MS analysis of serum from individuals with and without heterotopic ossification, and differences in the serum proteomic profile between healthy and diseased subjects were identified. Furthermore, our results indicate that normal wound healing signals can impact the ability to identify biomarkers, and a multi-protein panel assay, including osteocalcin preproprotein, osteomodulin precursor, and collagen alpha-1(v) chain isoform 2 preprotein, may provide a solution for HO detection and monitoring.
Keywords
collagen alpha-1(v), heterotopic ossification, Osteocalcin, Osteomodulin, SRM-MS
DOI
10.1186/s13018-017-0567-2
Recommended Citation
Edsberg, L., Crowgey, E., Osborn, P., & Wyffels, J. (2017). A Survey of Proteomic Biomarkers for Heterotopic Ossification in Blood Serum. Journal of Orthopaedic Surgery and Research, 12(1), 69-69. https://doi.org/10.1186/s13018-017-0567-2
Comments
© 2017 Edsberg et. al.
This is an open access article, made available under the under the CC-BY-NC-ND 4.0 license. http://creativecommons.org/licenses/by-nc-nd/4.0/